The Prognostic Value of Immune Factors in the Tumor Microenvironment of Penile Squamous Cell Carcinoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Prognostic Value of Immune Factors in the Tumor Microenvironment of Penile Squamous Cell Carcinoma
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-06-11
DOI
10.3389/fimmu.2018.01253
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Human papillomavirus (HPV)-independent vulvar squamous cell carcinoma has a worse prognosis than HPV-associated disease: a retrospective cohort study
- (2017) Jessica N McAlpine et al. HISTOPATHOLOGY
- Immune-checkpoint status in penile squamous cell carcinoma: a North American cohort
- (2017) Margaret Cocks et al. HUMAN PATHOLOGY
- Trends in incidence, mortality and survival of penile squamous cell carcinoma in Norway 1956-2015
- (2017) Bo T. Hansen et al. INTERNATIONAL JOURNAL OF CANCER
- Macrophages and prognosis of oral squamous cell carcinoma: A systematic review
- (2017) Alessandro Menna Alves et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Expression of Programmed Death Ligand 1 in Penile Cancer is of Prognostic Value and Associated with HPV Status
- (2017) Sarah R. Ottenhof et al. JOURNAL OF UROLOGY
- Adverse prognostic value of PD-L1 expression in primary resected pulmonary squamous cell carcinomas and paired mediastinal lymph node metastases
- (2017) Manuel D Keller et al. MODERN PATHOLOGY
- The immune contexture in cancer prognosis and treatment
- (2017) Wolf H. Fridman et al. Nature Reviews Clinical Oncology
- Distinct patterns of infiltrating CD8+ T cells in HPV+ and CD68 macrophages in HPV- oropharyngeal squamous cell carcinomas are associated with better clinical outcome but PD-L1 expression is not prognostic
- (2017) Kenneth Oguejiofor et al. Oncotarget
- Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
- (2017) Angel Garcia-Diaz et al. Cell Reports
- Clinical Significance of CD163+ and CD68+ Tumor-associated Macrophages in High-risk HPV-related Cervical Cancer
- (2017) Xiao-Jing Chen et al. Journal of Cancer
- Tumor PD-L1 expression is correlated with increased TILs and poor prognosis in penile squamous cell carcinoma
- (2017) Chuangzhong Deng et al. OncoImmunology
- The prognostic role of tumor infiltrating T-lymphocytes in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis
- (2017) Emma J. de Ruiter et al. OncoImmunology
- The ratio of CD4/CD8 T-cells in human papillomavirus-positive laryngeal squamous cell carcinoma accounts for improved outcome
- (2016) Duo Zhang et al. ACTA OTO-LARYNGOLOGICA
- Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approaches
- (2016) A. M. Udager et al. ANNALS OF ONCOLOGY
- A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17+ cell frequency
- (2016) Simone Punt et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Treg subsets in inflammatory bowel disease and colorectal carcinoma: Characteristics, role, and therapeutic targets
- (2016) Egbert H van Herk et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The "cancer immunogram"
- (2016) C. U. Blank et al. SCIENCE
- Assessment of the PD-L1 status by immunohistochemistry: challenges and perspectives for therapeutic strategies in lung cancer patients
- (2016) Marius Ilie et al. VIRCHOWS ARCHIV
- Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade
- (2016) P.-L. Chen et al. Cancer Discovery
- Clinicopathological and prognostic significance of regulatory T cells in patients with non-small cell lung cancer: A systematic review with meta-analysis
- (2016) Sha Zhao et al. Oncotarget
- Genetic Basis for PD-L1 Expression in Squamous Cell Carcinomas of the Cervix and Vulva
- (2016) Brooke E. Howitt et al. JAMA Oncology
- Swedish National Penile Cancer Register: incidence, tumour characteristics, management and survival
- (2015) Peter Kirrander et al. BJU INTERNATIONAL
- Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
- (2015) Padmanee Sharma et al. CELL
- Differential Expression of Immune-Regulatory Genes Associated with PD-L1 Display in Melanoma: Implications for PD-1 Pathway Blockade
- (2015) J. M. Taube et al. CLINICAL CANCER RESEARCH
- Classic and Nonclassic HLA Class I Expression in Penile Cancer and Relation to HPV Status and Clinical Outcome
- (2015) Rosa S. Djajadiningrat et al. JOURNAL OF UROLOGY
- Human Papillomavirus Prevalence in Invasive Penile Cancer and Association with Clinical Outcome
- (2015) Rosa S. Djajadiningrat et al. JOURNAL OF UROLOGY
- Pathologic and imunohistochemical characterization of tumoral inflammatory cell infiltrate in invasive penile squamous cell carcinomas: Fox-P3 expression is an independent predictor of recurrence
- (2015) José Vassallo et al. TUMOR BIOLOGY
- Prognostic and theranostic impact of molecular subtypes and immune classifications in renal cell cancer (RCC) and colorectal cancer (CRC)
- (2015) Etienne Becht et al. OncoImmunology
- Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma
- (2015) Simona Partlová et al. OncoImmunology
- Histologic and Immunohistochemical Assessment of Penile Carcinomas in a North American Population
- (2014) Mark J. Mentrikoski et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Human papilloma virus status of penile squamous cell carcinoma is associated with differences in tumour-infiltrating T lymphocytes
- (2014) Philipp Lohneis et al. VIRCHOWS ARCHIV
- Immunologic and metabolic characteristics of HPV-negative and HPV-positive head and neck squamous cell carcinomas are strikingly different
- (2014) Rosemarie Krupar et al. VIRCHOWS ARCHIV
- Two major pathways of penile carcinogenesis: HPV-induced penile cancers overexpress p16ink4a, HPV-negative cancers associated with dermatoses express p53, but lack p16ink4a overexpression
- (2013) Sebastian Mannweiler et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Combining routine morphology, p16INK4a immunohistochemistry, and in situ hybridization for the detection of human papillomavirus infection in penile carcinomas: A tissue microarray study using classifier performance analyses
- (2013) Alcides Chaux et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
- (2012) J. M. Taube et al. Science Translational Medicine
- The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis
- (2011) M J M Gooden et al. BRITISH JOURNAL OF CANCER
- M2 Macrophages Induced by Prostaglandin E2 and IL-6 from Cervical Carcinoma Are Switched to Activated M1 Macrophages by CD4+ Th1 Cells
- (2011) M. Heusinkveld et al. JOURNAL OF IMMUNOLOGY
- A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma
- (2011) Omid Hamid et al. Journal of Translational Medicine
- Macrophage Diversity Enhances Tumor Progression and Metastasis
- (2010) Bin-Zhi Qian et al. CELL
- Penile Squamous Cell Carcinoma Clinicopathological Features, Nodal Metastasis and Outcome in 333 Cases
- (2009) Gustavo Cardoso Guimarães et al. JOURNAL OF UROLOGY
- ORIGINAL ARTICLE: Regulatory T Cells in a Spectrum of HPV-Induced Cervical Lesions: Cervicitis, Cervical Intraepithelial Neoplasia and Squamous Cell Carcinoma
- (2008) Sreenivas Adurthi et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started